Autres langues BioNTech SE

Actions

BNTX

US09075V1026

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 29/09/2026			Varia. 5j.	Varia. 1 janv.
98,57 ^USD	-0,51%		-2,28%	+3,54%

29/09	Summit obtient un investissement de 2 milliards de dollars d’AstraZeneca et une collaboration sur des essais de médicaments contre le cancer	MT
28/09	Un initié de Biontech a vendu pour 6 012 500 $ d’actions, selon un récent document déposé auprès de la Securities and Exchange Commission (SEC)	MT

Autres langues

29/09	Summit Secures $2 Billion AstraZeneca Investment, Cancer Drug Trial Collaboration
28/09	Biontech Insider Sold Shares Worth $6,012,500, According to a Recent SEC Filing
28/09	BioNTech to Close 3 German Sites After Unsuccessful Sale Efforts
28/09	BioNTech to shutter three sites in Germany as no buyers emerge
28/09	BioNTech schließt drei deutsche Werke endgültig - Käufersuche gescheitert
28/09	Keine Käufer gefunden - drei Biontech-Werke machen dicht
28/09	Drei deutsche Biontech-Standorte werden geschlossen
25/09	European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading; Down for Week
24/09	PRESSESPIEGEL/Unternehmen
23/09	Neues Unternehmen von Biontech-Gründern heisst Arife
22/09	Biontech Insider Sold Shares Worth $7,860,757, According to a Recent SEC Filing
22/09	European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
21/09	European Equities Traded in the US as American depositary Receipts Rise in Monday Trading
18/09	Biontech Insider Sold Shares Worth $6,239,071, According to a Recent SEC Filing
18/09	European Equities Traded in the US as American Depositary Receipts Drop in Friday Trading
17/09	Pfizer Canada ULC And BioNTech SE Receive Health Canada Authorization For Omicron XFG-Adapted COMIRNATY COVID-19 Vaccine
17/09	Pfizer, BioNTech Secure Health Canada Authorization for Omicron XFG-Adapted COVID-19 Vaccine
17/09	Health Canada Authorizes Pfizer and BioNTech's Omicron XFG-Adapted COVID-19 Vaccine
16/09	Biontech Insider Sold Shares Worth $4,721,976, According to a Recent SEC Filing
16/09	Berenberg hebt Ziel für Biontech auf 140 Dollar - 'Buy'
15/09	European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
14/09	BioNTech, OncoC4 Report Positive Overall Survival Data From Phase 3 Trial of Gotistobart in Lung Cancer
14/09	BioNTech, OncoC4's Gotistobart Boosts Survival in Non-small Cell Lung Cancer Study
14/09	BioNTech verzeichnet Etappenerfolg mit neuem Lungenkrebsmittel
14/09	BioNTech says lung cancer drug candidate prolonged lives in trial